Therefore, in the pursuit of identifying AD risk factors, additional APOE gene polymorphisms in the transcriptional regulatory regions of the gene —the −1000 to +400 proximal promoter region in particular—were investigated [1]. This evidence concerns the gene APOE and Alzheimer disease.